Evidence map›Paper›PMID 27920703›Full record

ArticleCase reports in oncology

Kazuhiro Kitajima, Kazuhito Fukushima, Shingo Yamamoto, Toshiko Yamano, Haruyuki Takaki, Koichiro Yamakado, Yukako Nakanishi, Akihiro Kanematsu, Michio Nojima, Shozo Hirota

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Kazuhiro KitajimaDepartment of Radiology, Division of Nuclear Medicine and PET Center, Hyogo College of Medicine, Nishinomiya, Japan.
Kazuhito FukushimaDepartment of Radiology, Division of Nuclear Medicine and PET Center, Hyogo College of Medicine, Nishinomiya, Japan.
Shingo YamamotoDepartment of Urology, Hyogo College of Medicine, Nishinomiya, Japan.
Toshiko YamanoDepartment of Radiology, Hyogo College of Medicine, Nishinomiya, Japan.
Haruyuki TakakiDepartment of Radiology, Hyogo College of Medicine, Nishinomiya, Japan.
Koichiro YamakadoDepartment of Radiology, Hyogo College of Medicine, Nishinomiya, Japan.
Yukako NakanishiDepartment of Urology, Hyogo College of Medicine, Nishinomiya, Japan.
Akihiro KanematsuDepartment of Urology, Hyogo College of Medicine, Nishinomiya, Japan.
Michio NojimaDepartment of Urology, Hyogo College of Medicine, Nishinomiya, Japan.
Shozo HirotaDepartment of Radiology, Hyogo College of Medicine, Nishinomiya, Japan.
Hyogo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Choline is a new positron emission tomography (PET) tracer useful for detection of prostate cancer and metastatic lesions. We report a 70-year-old man with prostate cancer and multiple abdominal, pelvic, and inguinal node metastases. PET scans demonstrated accumulation of

Indexed as

CholineFDGPositron emission tomographyProstate cancer

Identifiers

PMID27920703
PMCPMC5126612
OpenAlexW2557068595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.